Senior Scientist
Moderna Therapeutics
Westborough, Massachusetts
Suresh Peddigari received his Ph.D. in Molecular Biology from Kumamoto University in Japan and post-doctoral training in Oncology at US institutions, exploring ribosome biogenesis impairment effect on lymphoma progression. He has 15 years of academic and industry research experience, expertise in small molecules, antisense oligonucleotides, CRISPR gene editing technologies for drug discovery and published in peer-reviewed journals.
He worked at Bristol Myers-Squibb as Senior Investigator and led early discovery target validation for immuno-oncology and inflammatory diseases drug discovery. Prior to Moderna, he was a Senior Scientist at Entrada Therapeutics in Boston exploring in-vtro and in-vivo pre-clinical evaluation of Anti-Sense Oligonucleotids (ASOs) for rare diseses and inflammatory targets as well as protein degraders for Oncology targets. Currently, Suresh serves as Molecular assays lead scientist at Moderna, developing assays for PK assessment of mRNA LNP therapeutics and supporting clinical studies.
Quantification of mRNA from mRNA-LNP Therapeutics by RT-qPCR
Monday, October 23, 2023
3:45 PM – 4:00 PM ET